Evidence map›Paper›PMID 30101939›Full record

ArticleInternal medicine (Tokyo, Japan)2018

Lambda Light Chain Non-crystalline Proximal Tubulopathy with IgD Lambda Myeloma.

Seiji Kishi, Fumiaki Obata, Hirokazu Miki, Motokazu Matsuura, Kenji Nishimura, Masanori Tamaki, Fumi Kishi, Taichi Murakami, Hideharu Abe, Kojiro Nagai and 2 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Seiji KishiDepartment of Nephrology, Graduate School of Biomedical Sciences, Tokushima University, Japan.
Fumiaki ObataDepartment of Nephrology, Graduate School of Biomedical Sciences, Tokushima University, Japan.
Hirokazu MikiDivision of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Japan.
Motokazu MatsuuraDepartment of Nephrology, Tokushima Red Cross Hospital, Komatsushima, Japan.
Kenji NishimuraDepartment of Nephrology, Graduate School of Biomedical Sciences, Tokushima University, Japan.
Masanori TamakiDepartment of Nephrology, Graduate School of Biomedical Sciences, Tokushima University, Japan.
Fumi KishiDepartment of Nephrology, Graduate School of Biomedical Sciences, Tokushima University, Japan.
Taichi MurakamiDepartment of Nephrology, Graduate School of Biomedical Sciences, Tokushima University, Japan.
Hideharu AbeDepartment of Nephrology, Graduate School of Biomedical Sciences, Tokushima University, Japan.
Kojiro NagaiDepartment of Nephrology, Graduate School of Biomedical Sciences, Tokushima University, Japan.
Masahiro AbeDepartment of Hematology, Endocrinology and Metabolism, Graduate School of Biomedical Sciences, Tokushima University, Japan.
Toshio DoiDepartment of Nephrology, Graduate School of Biomedical Sciences, Tokushima University, Japan.
Tokushima University · JPTokushima Red Cross Hospital · JPTokushima University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Light Chain Proximal Tubulopathy (LCPT) is a rare form of paraprotein-related kidney disease in which monoclonal free light chains damage the proximal renal tubular epithelial cells. We herein report the case of a 78-year-old woman who presented with anemia and kidney dysfunction. Serum and urine protein electrophoresis analyses revealed a monoclonal IgD and λ free light chains. Proximal tubular injury and the accumulation of λ light chains were found by kidney biopsy. Electron microscopy revealed no organized structure suggestive of crystals. LCPT was caused by IgD lambda myeloma and bortezomib and dexamethasone therapy led to very good partial response (VGPR) without a worsening of the kidney function.

Indexed as

AgedAnemiaAntineoplastic AgentsBiopsyBortezomibDexamethasoneFemaleHumansImmunoglobulin DImmunoglobulin Light ChainsKidney DiseasesKidney Tubules, ProximalMultiple MyelomaAntineoplastic AgentsBortezomibDexamethasoneImmunoglobulin DImmunoglobulin Light ChainsIgD λ myelomaLight Chain Proximal Tubulopathy (LCPT)paraprotein related kidney disease

Identifiers

PMID30101939
PMCPMC6355399
OpenAlexW2885804742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.